Quote | Forte Biosciences Inc. (NASDAQ:FBRX)
Last: | $0.51 |
---|---|
Change Percent: | 2.46% |
Open: | $0.511 |
Close: | $0.51 |
High: | $0.511 |
Low: | $0.5 |
Volume: | 2,030 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
News | Forte Biosciences Inc. (NASDAQ:FBRX)
2024-05-13 17:16:35 ET More on Forte Biosciences Seeking Alpha’s Quant Rating on Forte Biosciences Historical earnings data for Forte Biosciences Financial information for Forte Biosciences Read the full article on Seeking Alpha For further det...
Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced first quarter 2024 results and provided a business update. First Quarter 2024 Business Highlights ȁ...
Message Board Posts | Forte Biosciences Inc. (NASDAQ:FBRX)
Subject | By | Source | When |
---|---|---|---|
Huge volume today | Golden Cross | investorshub | 04/07/2023 4:04:54 AM |
Big step above 1,32 | mining101 | investorshub | 06/30/2022 5:56:55 PM |
Interesting | mining101 | investorshub | 06/27/2022 2:12:46 PM |
More | heyitsmeagain | investorshub | 04/27/2022 9:15:02 AM |
Ooooo looking for another squeeze but also, offering | heyitsmeagain | investorshub | 04/26/2022 6:18:14 PM |
News, Short Squeeze, Breakout and More Instantly...
Forte Biosciences Inc. Company Name:
FBRX Stock Symbol:
NASDAQ Market:
Forte Biosciences Inc. Website:
Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced first quarter 2024 results and provided a business update. First Quarter 2024 Business Highlights ȁ...
Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced its 2023 results and provided a business update. 2023 Business Highlights “Forte achieved a major...